Bayer AG reports Q3 sales of €9.7 billion and net loss of €1.0 billion

Reuters
2025.11.12 06:31
portai
I'm PortAI, I can summarize articles.

Bayer AG reported Q3 2025 sales of €9.7 billion, a 0.9% increase year-over-year. EBITDA rose 20.8% to €1.5 billion, while core earnings per share increased 137.5% to €0.57. However, the company faced a net loss of €1.0 billion due to litigation charges. Free cash flow fell to €0.6 billion, and net financial debt decreased to €32.7 billion. The Crop Science division performed well, while Pharmaceuticals sales remained stable. Bayer confirmed its outlook and announced Dr. Judith Hartmann will join the Board of Management in 2026.

Bayer AG reported group sales of €9.7 billion for the third quarter of 2025, representing a currency- and portfolio-adjusted increase of 0.9% compared to the same period last year. EBITDA before special items rose by 20.8% to €1.5 billion. Core earnings per share increased to €0.57, up 137.5%. Net income was minus €1.0 billion, impacted by special charges for litigations. Free cash flow declined to €0.6 billion, and net financial debt was slightly reduced to €32.7 billion. The Crop Science division posted higher sales and strong earnings growth, while Pharmaceuticals sales remained at the prior-year level and earnings declined. Consumer Health saw moderate sales growth and stable earnings. Bayer confirmed its group outlook. During the period, the company announced that Dr. Judith Hartmann will join the Board of Management on March 1, 2026, and succeed Wolfgang Nickl as Chief Financial Officer on June 1, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on November 12, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.